Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: PEG-aspargase and DEP regimen combination therapy for refractory Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis

Fig. 2

Changes in white blood cell counts (WBC) (a), platelet counts (b), alanine aminotransferase (ALT) concentrations (c), aspartate aminotransferase (AST) concentrations (d), total bilirubin (TBiL) concentrations (e), lactate dehydrogenase concentrations (f), fibrinogen (Fbg) concentrations (g), ferritin concentrations (h), and soluble CD25 concentrations (i) at the time of initial diagnosis of EBV-HLH, before, and 2 and 4 weeks after the L-DEP regimen

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us